BioMarin Pharmaceutical, Inc. (BMRN)
Current
- (-)
After Hours
Rating Performance
Rating Return
-1.3% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
-1.3% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
-1.3% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
-1.3% vs
Rating Accuracy
0% (0 of 1*)
FV Performance
FV Accuracy
11 Hits (157.14% Hit Rate)
FV Avg. Distance
+2.99%
FV Accuracy
20 Hits (166.67% Hit Rate)
FV Avg. Distance
+3.62%
FV Accuracy
20 Hits (105.26% Hit Rate)
FV Avg. Distance
+3.62%
FV Accuracy
20 Hits (46.51% Hit Rate)
FV Avg. Distance
+3.62%
About
CEO
Jean-Jacques Bienaimé
Employees
3,001
Industry
Endocrinology and Metabolism Biopharmaceuticals
Sector
Healthcare
Headquarters
San Rafael
Exchange
NASDAQ
Website
http://www.biomarin.comSummary Stats
Market Cap
17.1B
Revenue
2.1B
Net Income
142M
EPS
$0.75
Price-to-Earnings
122.07
Price-to-Book
3.71
Debt-to-Equity
0.39
News
Analyst Ratings
Price targets projected by 22 analysts
High
$187.00
Average
$108.73
Low
$80.00
Ratings calculated by 25 analysts
Buy
15
Hold
10
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q4 2022
Above by $0.07
$0.00 +100.0%
-0.07
-0.32
Up 100%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--